News | May 12, 2015

Men with High Estrogen Levels Could Be at Greater Risk of Breast Cancer

International study suggests causal connection, but exact mechanism for cancer growth remains unknown

men, breast cancer, high estrogen levels, Cancer Research UK

May 12, 2015 — Men with naturally high levels of estrogen may have a greater risk of developing breast cancer, according to research by an international collaboration including Cancer Research UK. The study was published in the Journal of Clinical Oncology.

This is the first time a link between estrogen levels in the blood and male breast cancer has been identified, despite the hormone’s connection to breast, womb and ovarian cancers in women.

Men with the highest levels of estrogen were two and a half times more likely to develop breast cancer than men with the lowest levels of the hormone.

Male breast cancer is very rare, with one man in every 100,000 diagnosed with breast cancer each year in the U.K. Around 350 male cases are diagnosed each year in the U.K. compared with nearly 50,000 cases of breast cancer in women.

The research at the National Cancer Institute in the United States was part of an international collaboration between Cancer Research UK, the National Cancer Institute and others.

The aim was to study a large international pool of men with breast cancer. The research compared estrogen levels in 101 men who went on to develop breast cancer with 217 healthy men.

Mark Cross, 46, a police officer from Cambridgeshire, was diagnosed with breast cancer in 2009. He had a mastectomy and then follow-up treatment of chemotherapy and radiotherapy. His treatment ended in September 2010. He said: "The police sometimes get a bit of a reputation for being macho but I had great support from everyone within the Metropolitan police service. Not many people know that men get breast cancer too and it was a complete surprise to be diagnosed. My advice to all men is if you develop a lump on your chest — or anywhere else on your body — get it checked by your doctor as soon as possible. I hope my experience will raise awareness for other men."

Study author Prof. Tim Key, Cancer Research UK's hormone and nutrition expert at the University of Oxford, said: "We've shown for the first time that just like some forms of the cancer in women, estrogen has a big role to play in male breast cancer. So now the challenge is to find out exactly what this hormone is doing to trigger this rare form of the disease in men, and why some men have higher levels of estrogen in their blood. Our discovery is a crucial step forward in understanding the factors behind male breast cancer."

The symptoms, diagnosis and treatment of male breast cancer are very similar to breast cancer in women. The main risk of developing the disease in men is age, and almost eight in 10 cases are diagnosed in those aged 60 and older.

Julie Sharp, M.D., head of health information at Cancer Research UK, said: "Breast cancer in men isn't discussed very often, so a diagnosis can be a big shock for the small group of men who develop the disease.

"Some of the estrogen variation in men will simply be natural, but for others there may be a link to being overweight. Fat cells in the body are thought to drive up the body's level of this hormone in men and women, so this is another good reason to try and keep a healthy weight.

"This early research is crucial in understanding why these men get breast cancer - so that one day we can treat it more effectively."

For more information: www.cancerresearchuk.org

Related Content

Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
DenseBreast-info.org Debuts  Spanish Language Video  About Dense Breasts
News | Breast Density | September 12, 2017
Breast cancer risks associated with breast density are the subject of a new Spanish language video launched recently by...
Asian Study Underlines Potential Value of Pressure-Guided Mammography
News | Mammography | September 11, 2017
Sigmascreening recently announced that a study of in total 15,898 in digital mammograms from 3,772 Asian women...
Delphinus Enrolls First Patient in Discover Breast Ultrasound Clinical Project
News | Ultrasound Womens Healthcare | September 08, 2017
September 8, 2017 — Delphinus Medical Technologies Inc.
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
Musculoskeletal Extremity Imaging in Medicare Beneficiaries Increased Over Two Decades
News | Orthopedic Imaging | September 06, 2017
A new study by the Harvey L. Neiman Health Policy Institute found that in the Medicare population, the utilization...
FDA Approves Guerbet's Dotarem for Pediatric Patients Younger Than Two Years
Technology | Magnetic Resonance Imaging (MRI) | September 06, 2017
September 6, 2017 — Guerbet LLC USA announced that the U.S.
FDA Clears Senographe Pristina Mammography System With Patient-Assisted Compression
Technology | Mammography | September 05, 2017
The U.S. Food and Drug Administration (FDA) cleared GE Healthcare’s Senographe Pristina with Self-Compression, the...
Overlay Init